IFF Pharma Showcases Next-Gen Excipients at CPHI Japan 2025 IFF Pharma Solutions is set to showcase its latest cutting-edge excipient technologies at CPHI Japan 2025, reinforcing its commitment to revolutionizing drug formulation and patient-centered pharmaceutical innovations. The event will take…
Johnson & Johnson to Build Advanced Biologics Facility in North Carolina Johnson & Johnson (the “Company”) is set to break ground on a new, cutting-edge biologics manufacturing facility in Wilson, North Carolina. The 500,000-square-foot facility represents a significant expansion of…
Pint Pharma Secures ANVISA Approval for BESREMi® in PV Treatment Pint Pharma and PharmaEssentia announced today that ANVISA (Brazilian Health Regulatory Agency) has approved BESREMi® (ropeginterferon alfa-2b) for the treatment of adult patients with Polycythemia Vera (PV). This milestone marks…
GRM Information Management to Exhibit at USCAP Annual Meeting GRM Information Management (GRM) is set to showcase its specialized pathology storage services at the prestigious United States and Canadian Academy of Pathology (USCAP) Annual Meeting, taking place from March 22-27…
Optum Rx to Modernize Pharmacy Payment Models Rising drug prices set by pharmaceutical manufacturers are placing significant financial strain on pharmacies across the United States. As the cost of prescription drugs increases, many pharmacies struggle to maintain high-quality patient care.…
ICON Fully Integrates Medidata Clinical Data Studio Medidata, a Dassault Systèmes brand and a leading provider of clinical trial solutions for the life sciences industry, has announced a significant partnership with ICON plc, a globally recognized clinical research organization (CRO)…
Faeth Therapeutics & GOG-F Launch Phase 2 Trial for Sapanisertib-Serabelisib in Endometrial Cancer Faeth Therapeutics (Faeth), a clinical-stage biotechnology company dedicated to pioneering novel metabolism-based therapeutic strategies, and The GOG Foundation, Inc. (GOG-F), a not-for-profit organization committed to advancing the…
City of Hope’s Phase 1 Trial Featured at SSO Annual Meeting City of Hope’s groundbreaking Phase 1 clinical trial has demonstrated promising results for patients suffering from colorectal and appendiceal cancer that has metastasized to the peritoneum. As one of…
LGM Pharma Invests $6 Million to Expand U.S. Drug Manufacturing Capabilities LGM Pharma, a leading provider of tailored active pharmaceutical ingredient (API) and contract development and manufacturing organization (CDMO) services, has announced a significant investment of over $6 million to…
Tenpoint Therapeutics Names Carol Kearney as Chief Commercial Officer Tenpoint Therapeutics Ltd. (“Tenpoint”), a global, clinical-stage biotechnology company dedicated to pioneering treatments that rejuvenate vision in the aging eye, has announced the appointment of Carol Kearney as Chief Commercial Officer…
Noramco Group Invests $25M in Halo Pharma for Sterile Injectables The Noramco Group Invests $25 Million in Halo Pharma’s Whippany Facility to Establish Sterile Injectable Manufacturing The Noramco Group, a fully integrated North American-based supplier of active pharmaceutical ingredients (APIs)…
ZYUS Life Sciences Closes Unsecured Loan and Amends Previous Loans ZYUS Life Sciences Corporation (“ZYUS” or the “Company”) (TSX-V: ZYUS), a Canadian-based life sciences company focused on the research, development, and commercialization of innovative cannabinoid-based pharmaceutical drug candidates for pain…